Novo Nordisk wants to innovate in new ways to find cures

The Novo Nordisk CSO wants a new approach to innovation.

Novo Nordisk CSO Marcus Schindler | Photo: Novo Nordisk / PR

Danish pharmaceutical company Novo Nordisk wants to keep innovating and finding new cures, according to a comment made by Novo Nordisk's new Chief Schientific Officer Marcus Schindler at a virtual media event in connection with a conference held by the American Diabetes Association.

"What I'm responsible for in my new role is to bring new hypotheses and new ideas for new treatments that address specific unmet medical needs," says Schindler.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs